Literature DB >> 1685667

The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

D Taverner1, I G Mackay, K Craig, M L Watson.   

Abstract

1. The effects of sustained moderate exercise in the sitting position on renal haemodynamics and glomerular filtration were measured in six normotensive patients with moderately impaired renal function and seven age-matched normal volunteers. 2. The changes in the effects of exercise on renal function induced by chronic cardioselective beta-adrenoceptor blockade by drugs with (epanolol) and without intrinsic sympathomimetic activity (atenolol) were examined. 3. Both beta-adrenoceptor blockers attenuated the heart rate increase with exercise, but only atenolol lowered blood pressure significantly. In resting volunteers on atenolol, associated with the fall in blood pressure there was a significant reduction in glomerular filtration rate. 4. Glomerular filtration fell significantly in all groups with exercise, and renal blood flow also fell in parallel. These changes were not influenced by drug treatment. 5. The exercise-induced rise in PRA was suppressed by atenolol but not by epanolol. 6. The renal function and haemodynamic responses to moderate exercise does not appear to be mediated by the systemic renin-angiotensin system or by beta 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685667      PMCID: PMC1368536          DOI: 10.1111/j.1365-2125.1991.tb03917.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

Review 1.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 2.  Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.

Authors:  M Beaufils
Journal:  Am J Hypertens       Date:  1989-11       Impact factor: 2.689

3.  Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?

Authors:  G Leonetti; L Sampieri; C Cuspidi; L Terzoli; L Rupoli; M Fruscio; R Gradnik; A Zanchetti
Journal:  J Hypertens Suppl       Date:  1985-12

Review 4.  Beta blockers and renal function: a reappraisal.

Authors:  M Epstein; J R Oster
Journal:  J Clin Hypertens       Date:  1985-03       Impact factor: 3.738

5.  Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Authors:  I G Mackay; A M Macnicol; H J Smith; A D Cumming; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

6.  Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise.

Authors:  P Hespel; P Lijnen; L Vanhees; R Fagard; A Amery
Journal:  J Appl Physiol (1985)       Date:  1986-01

7.  Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.

Authors:  H J Smith; S E Halliday; D C Earl; D Stribling
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

8.  Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.

Authors:  J S Larsen; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

Review 9.  Adrenergic blocking agents and the kidney.

Authors:  J H Bauer
Journal:  J Clin Hypertens       Date:  1985-09       Impact factor: 3.738

10.  Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

Authors:  T H Pringle; P C O'Connor; A J McNeill; M B Finch; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.